- Joined
- Jun 6, 2002
- Messages
- 13,884
- Reaction score
- 4,441
I agree with the Tamiflu. I tell them: "I will prescribe Tamiflu if you want it, but it won't make you better much faster, won't reduce severity of symptoms, will be expensive, and could cause side effects. Do you still want me to prescribe it?"
I say something similar for the swabs: "We can do the swabs if you want, but you will wait 2 hours for the results, won't change anything I prescribe, and you will still be going home. Would you rather I just discharge you now?"
I searched for Tamiflu and found this page. Tamiflu shortens duration by about 24 hours and will stop the virus from shedding in nasal secretions after 72 hours of treatment. As some of you know, I do consulting work for a hedge fund for products/drugs going before the FDA for approval. One recent application caught my attention as it relates to emergency medicine. Although I can't mention many specifics (cost, financial forecasts, etc. due to a non-disclosure agreement), the basis of the story is public and I can comment on it.
On Monday, the FDA granted priority review to Genentech's novel baloxavir marboxil. It's a inhibitor of cap-dependent endonuclease protein within the flu virus. This is responsible for viral replication. This means that strains resistant to Tamiflu will be treatable with baloxavir marboxil. It's a single dose that also reduces severity by 24 hours (average duration of symptoms was 54 hours instead of 80), but more importantly, it reduced shedding of the virus significantly at 24 hours post-administration. That means people are much less infectious. This has a great deal of implication in preventing flu outbreaks by treating patients promptly since most are infectious up to 96 hours after onset of symptoms. One pill in the ER or urgent care can treat them.